ArticleBMC anesthesiology2026
Association and predictive value of preoperative high-sensitivity C-reactive protein for postoperative atrial fibrillation after video-assisted thoracoscopic lobectomy: a cohort study using the INSPIRE database.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPostoperative atrial fibrillation (POAF) is a common and serious complication following video-assisted thoracoscopic surgery (VATS), which affects patients' medical outcomes and quality of life. The predictive value of high-sensitivity C-reactive protein (hs-CRP) as an inflammatory marker for POAF in non-cardiac surgeries remains unclear. This study aims to investigate the association and predictive capability of preoperative hs-CRP levels with postoperative new-onset atrial fibrillation.
methodsThis study employed a retrospective cohort design, analyzing data from the INSPIRE database, which included 3,219 patients who underwent thoracoscopic lobectomy. Patients were classified into low-risk, moderate-risk, and high-risk groups based on preoperative hs-CRP levels. Multivariable logistic regression models were used to assess the independent association of hs-CRP with the occurrence of POAF in different risk groups. Additionally, the incremental predictive utility of hs-CRP for POAF was evaluated using C-statistics, continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI), in order to quantify the improvement in predictive accuracy when including hs-CRP in existing risk models. Feature importance calculations and predictive models were generated using the Boruta algorithm and machine learning methods.
resultsThe incidence of clinically recognized POAF increased progressively across hs-CRP categories (2.9% in the low-risk group, 6.0% in the intermediate-risk group, and 9.3% in the high-risk group; P for trend < 0.001). After multivariable adjustment using preoperatively available covariates, the high hs-CRP group remained significantly associated with clinically recognized POAF compared with the low hs-CRP group (OR 2.33, 95% CI 1.31-4.14; P = 0.004). Adding hs-CRP to a baseline clinical model including age, sex, BMI, RCRI score, and extent of resection improved the C-statistic from 0.758 to 0.845 (P < 0.001), with significant improvements in continuous NRI and IDI. However, these reclassification metrics should be interpreted as statistical risk refinement rather than evidence of clinically actionable reclassification.
conclusionPreoperative high-sensitivity C-reactive protein is associated with an increased risk of clinically recognized POAF after VATS lobectomy. Its inclusion in baseline models improves statistical risk stratification, pending further prospective clinical validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.